Skip to main content
Fig. 1 | Clinical and Translational Allergy

Fig. 1

From: Looking forward to new targeted treatments for chronic spontaneous urticaria

Fig. 1

Potential targets in the treatment of chronic urticaria. Baso basophil, CRTH chemoattractant receptor-homologous molecule expressed on Th2 cells (DP2), Eos eosinophil, H1/4R histamine 1/4 receptor, NK neurokinin, C5 complement 5, IgE immunoglobulin, IL interleukin, LTR leukotriene receptor, PI3 K phosphoinositide 3-kinase, S1P sphingosine-1-phosphate, SHIP SH2-containing inositol phosphatase 1, Syk spleen tyrosine kinase, TSLP thymic stromal lymphopoietin. 1Currently available, 2under investigation, 3hypothetical

Back to article page